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ABSTRACT
Objective: Heart septal defects (HSD) account for 50% of the congenital heart malformations and are characterized by the hole in the wall of tissue 
which separates the heart chambers. The known causes of the SD are multifactorial and complex inheritance.
Methods: Isolated 15 subjects with ostium secundum atrial SD (OS-ASD) and one subject with perimembranous ventricular SD (VSD) among 125 
clinically diagnosed SD were included in the study. Sanger sequencing was performed for all the exons of TBX5 genes using genomic DNA of these 
patients.
Results: Sequence variation c.444 G>A substitution, leads to the alteration of tryptophan residue into premature stop codon at codon 148. We observed 
a divergent phenotype within a family of four, where one sibling and the mother had OS-ASD, another sibling had phenotype of perimembranous VSD, 
and the father had normal genotype.
Conclusion: We believe that this novel sequence variant in TBX5 gene is one of the factors in the SD and may hold a key determining the role of TBX5 
gene in the heart development.
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INTRODUCTION
Human heart is a 4-chambered organ with each chamber having an 
important role in storing and pumping the blood flow to and from 
specific body regions. The structure responsible for this separation 
is called cardiac septum. The septum is a wall of tissue between left 
and right heart’s structure. A hole in this tissue wall is broadly termed 
as heart septal defect (HSD), and this defect leads to abnormal blood 
flow, thereby, reducing the heart’s efficiency. HSD are the most 
common structural cardiac malformations affecting approximately 
1% of live-born and accounts for 50% of congenital heart defects 
(CHDs). Various epidemiological studies have demonstrated that 
CHDs have a genetic predisposition as observed in most of the 
cases [1,2]. Especially, transcription factor genes, primarily NKX2-5, 
GATA4, and TBX5 have been implicated in regulating the septal 
development during prenatal stages [3]. The transcriptional genes 
synergistically influence each other in a complex pathway in the 
heart development, including the septal formation [4]. Mutation or 
changes in these genes disrupt the interactions and could lead to the 
cause of HSD [5].
TBX5 belongs to a phylogenetic family of genes sharing a common DNA 
binding domain, T-box [6]. Being a transcriptional activator, this gene 
plays a major role in the development of heart especially differentiation 
of mesoderm as well as formation and specification of the upper 
limb identity [7]. Mutation in TBX5 is known to cause Holt-Oram 
syndrome (HOS) and associated cardiac malformations mainly atrial 
and ventricular SD (VSD) [8,9]. Among the known associated factors 
for CHDs, about 3-5% cases are attributed to following the Mendelian 
Inheritance, and the known association with the HOS [10] provides the 
required evidence in support of this. However, the etiology of isolated 
SD in these cases is poorly understood. In view of that, we analyzed 
DNA from 125 patients with SD and further sequenced the exon regions 
of TBX5 gene, to find out the novel variant.
METHODS
Clinical details of the patients
Patients were recruited at Cardiology Department, Kasturba Hospital, 
Manipal, for the study from June 2012 to December 2015, after 
obtaining written consent. The cardiac complications were examined by 
the cardiologist and subsequently confirmed using echocardiography. 
We also included the patient’s parents and investigated the cases for 
assessing the familial history. The study was approved by Institutional 
Ethical Committee.
Mutational analysis
Genomic DNA was extracted from the peripheral blood of 125 patients. 
The whole exons and partial flanking introns of TBX5 gene were amplified 
by polymerase chain reaction (PCR) in a 25 µl master mix containing 
10× PCR buffer, 10 pmol/µl of forward and reverse primers, 1.5 mmol/L 
MgCl2, 4% dimethyl sulfoxide, 4 mmol dNTPs, Taq DNA polymerase 
(5 units/ml, Takara), and 100 ng template DNA. The program for the 
thermal cycling was set as initial denaturation at 94°C for 5 minutes 
followed by 35 cycles of denaturation for 45 seconds; subsequent 
annealing for exon 1, exon 2, exon 5 at 61°C, for exon 3, exon 4, exon 7 
at 59°C and for exon 6 and exon 9 at 65°C for 30 seconds each and 72°C 
for 45 seconds followed by a final extension at 72°C for 10 minutes. The 
primer sequence of TBX5 gene is represented in Table 1.
The PCR products were then sequenced by the BigDye Terminator ABI 
Prism Sequencing kit (Applied Biosystems, Foster City, CA, USA), and 
run on ABI 3130 XL sequencer. Sequencing was carried out twice to 
confirm the variant using both forward and reverse primers.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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In silico analysis of the variant
Acquired sequences were compared with the reference sequence 
(NM_000192.3) using BLAT [11]. The observed variations were 
confirmed using bioinformatics tools such as UCSC genome 
browser [12], mutation taster [13], PANTHER [14], human genome 
mutation database [15], and 1000 genome database [16]. Relevant 
literature was reviewed to check the novelty of the obtained sequence 
variant. Multiple sequence alignment was carried out using ConSurf [17] 
whereas, structural analysis and the visualization of protein was also 
carried out using Protein Data Bank (PDB) file - 4 s0H [18].
RESULTS
Clinical features
Out of 125 study subjects with SD, 102 were ostium secundum atrial SD 
(OS-ASD), 9 were sinus venosus ASD, 12 were perimembranous VSD, 
1 was muscular VSD, and 1 was atrio VSD patient. Analysis of the data 
indicated that 16 out of 125 subjects are heterozygous for a nonsense 
variant in c.444G>A (p. W148X) leading to premature termination 
of TBX5 protein in the center of T-box domain. These 16 subjects 
included in this study, were ascertained through echocardiography 
and transoesophageal echocardiography (Fig. 1). The gender ratio 
of the recruited subjects was 1:1, with the mean septum size 19 mm 
(4-30 mm). In this study, the patients were screened for TBX5 gene 
variation. In 15 cases, we observed that all the subjects exhibited OS-
ASD. Surprisingly, sister of a female proband showed a clinical picture of 
divergent phenotype, perimembranous VSD which was confirmed later. 
The family of this proband was further investigated with prior consent 
where the mother too showed OS-ASD phenotype during the imaging 
study, and the father was normal. The pedigree of the family with the 
inheritance of isolated SD is represented in Fig. 2a.
Mutational analysis
DNA samples of both parents and the sibling were subjected to 
molecular analysis, DNA sequencing of PCR-amplified exon 5 of TBX5. 
Mother was heterozygous to TBX5, c.444G>A and the father was normal. 
This variant was also found de novo in 13 sporadic cases with the 
similar clinical phenotype of OS-ASD. This novel heterozygous variant, 
Fig. 1: Echocardiography of the patients showing heart septal 
defects (SD). (a) Apical four chamber view 2DE showing ostium 
secundum atrial SD, (b) Plax view- perimembranous VSD, color 
flow imaging showing left to right shunt
ba
Fig. 2: Identification of a novel TBX5 variant, c.444G>A (p. W148X) associated with the heart septal defects. (a) Pedigree of an Indian 
family showing inherited TBX5 variant across the generations. Square represents male and circle represents female; arrow indicates the 
proband, darkened circle represents affected individuals, (b) Sequence analysis of TBX5 exon 5; (1) Affected individual and (2) Normal 
individual, and (c) Single base pair substitution altering tryptophan to stop (W148X)
cb
a
Table 1: List of PCR primers of TBX5 gene and the product size


















































The primer sequences are acquired from Granados-Riveron et al. 2012. 
FP: Forward primer, RP: Reverse primer, E: Exon, and PCR: Polymerase chain 
reaction
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c.444G>A substitution, leads to the alteration of tryptophan residue 
into premature stop codon at codon 148 (p. W148X; TGG → TGA), 
resulting in the truncated protein, represented in the chromatogram 
(Fig. 2b and c). The TBX5 gene represented in Fig. 3a comprises a 
T-box domain and a transactivation domain. The novel variant is shown 
in Fig. 3b. The Wild type tryptophan residue at codon 148 is highly 
conserved across the species from zebrafish to humans as specified in 
Fig. 3c, resulting in a truncated protein with 147 amino acids. Cross-
species alignment indicated that the mutated amino acid residue is 
functionally important suggesting that the variant is possibly damaging 
the protein structure and function. This nonsense variant results in 
the absence of the functional and binding domain. Further, protein 
modeling was done using PyMOL with the help of PDB file 4 s0H, to 
find out the interaction for ternary complexes of atrial natriuretic factor 
(ANF)-TBX5-NKX2-5 genes (Fig. 4). We observed that there is a loss of 
binding capacity to ANF factor because of premature truncation in the 
TBX5 gene.
DISCUSSION
CHD are multifactorial as well as heterogeneous in nature [19]. SD 
are most common cause of CHDs and occur sporadic or familial 
forms [20,21]. Familial forms may follow atypical patterns of 
inheritance resulting in variable phenotype, such that TBX5 gene 
Fig. 4: Molecular modeling of two asymmetric ternary complexes 
of ANF-TBX5-NKX2-5 proteins. TBX5 is colored with green and 
missing residues are shown in cyan, NKX2-5 is colored with red, 
mapping of W148 is shown in magenta color, DNA backbone is 
colored brown
Fig. 3: Schematic representation showing genomic and proteomic organization of TBX5 gene. (a) Structure of TBX5 gene indicating the 
substitution from G → A at exon 5, (b) Wild-type TBX5 protein and premature termination due to stop codon resulting in truncated TBX5, 
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mutation c.444G>A; detected in the recruited subjects with SD. In 
this study, among the HSDs, the OS-ASD forms a significant kind of 
phenotype. Out of 125 cases subjected to TBX5 exon analysis, we 
observed a very close association between OS-ASD and TBX5 mutation. 
In this case, three members of a family shown to have atypical pattern 
of disease inheritance. The mutation was inherited from the mother 
to both the children, but the resulting phenotype diverged in these 
siblings. The reason for this diverse phenotype following the same 
mutation is still unclear. The cross-species alignment of TBX5 protein 
showed that the altered tryptophan residue is evolutionarily conserved 
throughout the vertebrates, indicating its functional importance [22]. 
The understanding of the genetic mutations is an important aspect in 
deciphering the consequential clinical phenotypes [23,24]. This study 
was performed to investigate the basis of this divergent phenotype 
related to a single gene mutation. The genetic study was further 
analyzed using bioinformatics tools, and the variant was estimated to 
be disease causing by Mutation Taster and with high probability to be 
damaging by PANTHER.
For this purpose, we carried out complete comparative protein modeling 
by PyMol, to locate this novel variant, which may have an impact on 
DNA binding domain and the dimerization interface. DNA binding 
domains of NKX2-5 (138-197 amino acid residues of homeodomain) 
and TBX5 (58-239 amino acid residues of T-box domain) forms a 
complex and binds to specific DNA motif. This infers that the DNA 
binding domains of these genes are essential for functional and physical 
interactions as well as for synergistic activation of other transcription 
factors. The interaction between TBX5-CRM1 has been documented, 
whereby, mutations in TBX5 affects the relocation [25]. The variant, 
c.444G>A is found to be located at α-helix 2 sites. Further, α-helix 3 and 
310-helix C play a crucial role as DNA recognition elements by binding to 
DNA. The premature stop codon at position 148, leads to a probable loss 
in the interaction of TBX5 with CRM1 and binding of ANF-252 DNA [26]. 
Hence, this variant can be considered as hot spot mutation in the TBX5 
gene and to be associated with isolated and nonsyndromic SD. However, 
the results of this study can further be characterized to explore the 
functional mechanisms leading to the heart septal development.
A truncation mutation p. Glu69Ter was identified in the exon 3 of TBX5, 
in the affected family members with dominant phenotype, HOS. This 
truncating mutation is a transversion from G → T that converts GAA 
(glutamate residue) to TAA (stop codon). Hence, this mutation results 
in the haploinsufficiency in patients with HOS suggesting that HOS 
are caused by mutation in TBX5 [27]. Another study reported a novel 
mutation in the exon 5 of TBX5, p. Y136X. This mutation was identified 
in the members of two unrelated families having HOS [28]. A novel 
nonsense mutation in the exon 3 of TBX5 associated with single HOS 
patient, 192G>A (p. W64X) results in the truncation of TBX5 polypeptide 
by 88%. Here, the substitution happens at the 2nd position of codon 
64 where tryptophan residue changes into stop codon and is located 
at the T-box domain [29]. A study demonstrated that expressivity of 
malformation in patients with HOS cannot be predicted by either by the 
location of the mutation in the T-box domain or the TBX5 mutation [30]. 
However, in our study, the affected individuals with nonsense variant 
are devoid of any HOS phenotype.
CONCLUSION
We report for the first time a novel nonsense variant in an Indian family 
with different phenotype and this variant is de novo in 13 sporadic 
cases without any limb deformities. This study aids in expanding the 
mutation spectrum of TBX5 in the Indian population and provides a 
new insight into understanding the molecular mechanism of TBX5 
mutation underpinning OS-ASD.
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